Researchers develop TRFS, a non-invasive radio frequency technique that can suppress or excite deep-brain activity to treat depression, epilepsy, and Parkinson’s.

HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the ...

A new study found that precise application of radio waves can change the activity of brain cells in ways that could counter neurological conditions.

Deep Brain Stimulation (DBS) is being used in a new study funded by the NIH at University of California San Francisco to treat chronic pain, and so far has shown a 60% reduction in pain in six ...

A new study found that precise application of radio waves can change the activity of brain cells in ways that could counter neurological conditions.

The findings, to be published online Dec. 10 in eLife, hold direct implications for an increasingly widespread therapeutic approach called deep-brain stimulation. They point to DBS's potential for ...

New research suggests transcranial electrical stimulation could reduce obsessive–compulsive disorder symptoms. Discover more.

Deep brain stimulation (DBS) is a treatment for various neurological conditions such as Parkinson’s disease and obsessive-compulsive disorder. It involves surgically implanting an electrode into your ...

Patent Approval Reinforces Nexalin’s Leadership in Non-Invasive Brain Stimulation for Addiction Treatment HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) ...